Improved accuracy
Outstanding accuracy including strong low-glucose range performance1
Readings every minute
Automatic readings every minute†
Our longest-lasting sensor
The first 15-day CGM sensor in the US*
Accurate, stable, and consistent over 15 days1—no fingersticks§, no user calibration, no code entryII.
For commercially insured and cash-paying patients
Prescribe two FreeStyle Libre 2 Plus sensors [30-day supply, filled monthly; sensor refills: PRN or 12 additional refills (1-year supply)]
If your commercially insured patients are asked to pay >$75 for two sensors or have questions about coverage and costs, please have patients call 844-330-5535.
Commercially insured and cash-pay patients can fill their Rx at participating pharmacies# for the FreeStyle Libre 2 Plus sensor.
For your Medicare or Medicaid patients
Step 1: To see if your patient is covered under Medicare Fee-for-Service, Medicare Advantage, or Medicaid, refer to the CMS Continuous Glucose Monitors coverage criteria**2
Step 2: Find a DME supplier†† that carries the FreeStyle Libre 2 Plus sensor
Step 3: For Medicare patients, complete a Standard Written Order Form
Step 4: Explain to your patient they should expect a call from the DME supplier†† for any additional information, if needed. Once approved, the product will be shipped to your patient’s home
For questions regarding Medicare Fee-for-Service coverage, please visit www.medicare.gov
To be eligible for Medicare coverage, the prescription must include both the reader and sensors, and the reader must be used on some days every month.
|
DME SUPPLIER |
PHONE
|
FAX
|
|---|---|---|
|
Advanced Diabetes Supply |
866-976-9110 |
760-496-0234 |
|
Byram Healthcare/Apria |
800-775-4372 |
866-387-1127 |
|
CCS Medical |
800-599-7521 |
800-557-8256 |
|
Edgepark Medical Supplies |
844-619-4650 |
866-510-6583 |
|
Edwards Health Care Services |
800-951-1725 |
502-657-0237 |
|
Solara Medical Supplies/AdaptHealth |
844-381-8032 |
800-999-7021 |
|
United States Medical Supply |
877-270-6508 |
866-347-8544 |
NRC Code for the FreeStyle Libre 2 Plus sensor
NRC-57599-0835-00
For questions related to Tandem t:slim X2 pump, t:connect app¶ or Control-IQ algorithm, you can contact Tandem's Customer Service at 1-877-801-6901.
FreeStyle Libre 2 Plus sensor is indicated for use in people with diabetes age 2 and older.
Medicare and other payor criteria may apply.
* Based on patient applied sensors currently on market in the US.
† FreeStyle Libre 2 Plus sensor connects via Bluetooth to the Tandem t:slim X2 insulin pump. Glucose data is visualized on the t:connect mobile app and t:slim X2 insulin pump every minute.
‡ Based on product features including up to 15-day wear period, automatic readings every minute and accuracy data.
§ Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.
II Calibration or coding not required by the user.
¶ The information on the t:connect mobile app display may not be identical to the current status of your pump. Wireless uploads from the t:connect mobile app to the cloud-based t:connect web application require a compatible phone and an internet or wireless data connection. Uploads to the t:connect web application do not take place in real time and should not be relied upon by healthcare providers or caregivers for remote patient monitoring. Standard carrier data rates may apply.
# Participating pharmacies are subject to change without notice. Product availability may vary by retailer.
** Patients must meet Medicare eligibility coverage criteria.
†† DMEs are subject to change without notice.
References: 1. FreeStyle Libre 2 User's Manual. 2. Local Coverage Determination (LCD) L33822, Glucose Monitors, https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33822.
Important Safety Information for Tandem t:slim X2 insulin pump: RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in individuals 6 years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible iCGM (sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons 6 years of age and greater.
WARNING: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.
Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
t:connect Mobile App: The t:connect mobile app is intended to be a secondary display for compatible Tandem Diabetes Care insulin pumps and is capable of wirelessly uploading pump data it receives into the t:connect web application. The t:connect mobile app is not intended to control an insulin pump and is not intended to be a replacement for the information displayed on your insulin pump. Dosing decisions should not be made based on the secondary display device. The user should follow instructions on the continuous glucose monitoring system and insulin pump. This secondary display device is not intended to replace self-monitoring practices as advised by a physician.
ADC-82955 v1.0
Important Safety Information
FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.
FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre 2 or FreeStyle Libre 3 systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose alarms and readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855‑632‑8658 or FreeStyleLibre.us for safety info.
FreeStyle Libre Pro: The FreeStyle Libre Pro Flash Glucose Monitoring System is a professional continuous glucose monitoring (CGM) device indicated for detecting trends and tracking patterns and glucose level excursions above or below the desired range, facilitating therapy adjustments in persons (age 18 and older) with diabetes. The system is intended for use by health care professionals and requires a prescription.
IMPORTANT: The device may inaccurately indicate hypoglycemia. The results of the clinical study conducted for this device showed that 40% of the time when the device indicated that user sensor glucose values were at or below 60 mg/dL, user glucose values were actually in the range of 81-160 mg/dL. Therefore, interpretation of the FreeStyle Libre Pro Flash Glucose Monitoring System readings should only be based on the trends and patterns analyzed through time using the reports available per the intended use.
CONTRAINDICATIONS: Remove the Sensor before MRI, CT scan, X-ray, or diathermy treatment.
WARNINGS/LIMITATIONS: The FreeStyle Libre Pro System does not provide real-time results and patients should adhere to their blood glucose monitoring routine while using the system. If a sensor breaks, contact physician and call Customer Service. Patients with high levels of ascorbic acid (Vitamin C) or salicylic acid (used in Aspirin) or severe dehydration or excessive water loss may experience inaccurate results with this system. The FreeStyle Libre Pro System is not approved for pregnant women, persons on dialysis, or recommended for critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. Review all product information before use or contact Abbott Toll Free (855-632-5297) (or visit provider.myfreestyle.com) for detailed indications for use and safety information.
The product images are for illustrative purposes only.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-45115 v18.0
The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to leave this site?
